I think you are on the money there. Devices aren't as sexy as drug trials generally so device business model is more of the long game. It is still attractive as a business because it provides access to top hospitals in oncology and that can't be discounted down the track.
- Forums
- ASX - By Stock
- OSL
- Ann: OncoSil achieves first commercial sale
Ann: OncoSil achieves first commercial sale, page-32
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.19M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $9.782K | 752.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 11636360 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 4307472 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 9237560 | 0.013 |
15 | 9117522 | 0.012 |
18 | 8704466 | 0.011 |
16 | 11297430 | 0.010 |
12 | 4521222 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 4307472 | 9 |
0.015 | 2205000 | 9 |
0.016 | 4392825 | 5 |
0.017 | 5155548 | 3 |
0.018 | 1532208 | 3 |
Last trade - 14.13pm 02/10/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |